Cleerly LABS vs EchoGo Pro

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Cleerly
VS
by Ultromics

AI Verdict

Cleerly LABS and EchoGo Pro both aim to enhance the diagnosis of coronary artery disease but utilize different imaging modalities. Cleerly LABS focuses on detailed plaque and stenosis characterization from CCTA scans, providing anatomical insights into atherosclerosis. EchoGo Pro, conversely, automates the analysis of stress echocardiograms to improve functional assessment and diagnosis of CAD.

Choose Cleerly LABS if…

Choose Cleerly LABS if your primary goal is a comprehensive, AI-powered anatomical assessment of coronary arteries using CCTA. This tool is ideal for quantifying plaque volume and type, detecting stenosis, and tracking disease progression over time to inform personalized heart disease management strategies.

View Cleerly LABS →

Choose EchoGo Pro if…

Choose EchoGo Pro if you need to automate and enhance the analysis of stress echocardiograms for the rapid and accurate diagnosis of coronary artery disease. This cloud-based solution is best suited for improving efficiency in echo labs and providing near-instant, standardized reports for functional cardiac assessment.

View EchoGo Pro →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Cleerly LABS EchoGo Pro
Pricing Varies Contact vendor for pricing
Deployment Cloud, On-premise Cloud-based (SaaS)
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

EchoGo Pro

EchoGo Pro emphasizes a cloud-based SaaS model requiring no software installation or extensive training, facilitating easier adoption and seamless integration with existing clinical workflows (DICOM, HL7). Cleerly LABS, while web-based, mentions an on-site 'Cleerly Proxy' for data transfer, which might imply a slightly more involved setup.

Clinical Value

Cleerly LABS

While both tools are FDA-cleared and offer significant clinical value, Cleerly LABS provides a more comprehensive approach by offering detailed coronary plaque assessment (volume, type), stenosis quantification, and the ability to track disease progression over time from CCTA. This allows for more personalized heart disease management and a proactive stance on preventing heart attacks, going beyond automated diagnosis of CAD.

Pricing & Value

Tie

Cleerly LABS offers transparent per-analysis pricing, but the high out-of-pocket cost for patients could be a barrier. EchoGo Pro lacks transparent pricing, requiring vendor contact, yet it mentions reimbursement codes for related products, which could imply easier financial integration for providers. Without direct pricing for EchoGo Pro, a definitive winner on value cannot be determined.

Enterprise Readiness

EchoGo Pro

Both solutions are cloud-based, FDA-cleared, HIPAA compliant, and have BAAs. However, EchoGo Pro explicitly highlights its 'vendor-neutral system' and 'seamless integration with existing clinical workflows (DICOM, HL7)' without requiring software installation. This suggests a more adaptable and less burdensome deployment within diverse enterprise IT environments compared to Cleerly LABS' reliance on an on-site proxy for data transfer.

Innovation

Cleerly LABS

Both tools are innovative in their respective domains. Cleerly LABS stands out by focusing on comprehensive coronary plaque characterization and tracking disease progression from CCTA, with a stated mission to 'eliminate heart attacks.' This represents a more advanced and proactive approach to cardiovascular disease management beyond automating existing diagnostic procedures like stress echocardiography.

Support & Docs

Cleerly LABS

Cleerly provides clear support hours (Monday-Friday, 10 am ET to 6 pm ET) and dedicated email support, alongside a range of resources including billing guidelines and a payor policy lookup tool. While Ultromics offers customer support and various resources like clinician user manuals and webinars, Cleerly's explicit support availability and practical billing resources give it a slight edge in transparency and direct assistance for providers.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Cleerly LABS EchoGo Pro
Tool Name Cleerly LABS EchoGo Pro
Company Cleerly Ultromics
Primary Imaging Modality Coronary CT angiography (CCTA) Stress echocardiography
Core Function AI-powered analysis of CCTA to detect, quantify, and characterize atherosclerosis and stenosis. AI-powered automated stress echocardiography analysis to improve diagnosis of coronary artery disease.
Key Specific Feature Comprehensive coronary plaque assessment (volume, type), stenosis detection, ischemia detection (with module), tracking disease progression. Automated identification of coronary artery disease (CAD), near-instant comprehensive reports, vendor-neutral system compatible with any PACS.

Videos

Demos, reviews, and walkthroughs featuring Cleerly LABS and EchoGo Pro.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Cleerly LABS is an AI-powered software that analyzes coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. In contrast, EchoGo Pro is an AI-powered cloud solution that automates stress echocardiography analysis to improve the diagnosis of coronary artery disease.
Cleerly LABS offers comprehensive coronary plaque assessment, including volume and type, stenosis detection and quantification, 3D visualization of coronary arteries, and personalized heart disease risk assessment, with an optional module for ischemia detection. EchoGo Pro provides near-instant, comprehensive reports from automated echocardiogram analysis, focusing on the identification of coronary artery disease.
Cleerly LABS explicitly lists 'Tracking disease progression over time' as a key feature, allowing physicians to monitor changes in atherosclerosis and stenosis. EchoGo Pro's description focuses on improving the diagnosis of coronary artery disease through automated analysis, without explicitly mentioning long-term progression tracking.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.